Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study

Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Annals of Allergy, Asthma & Immunology - Volume 110, Issue 4, April 2013, Pages 295-299

Marc A. MD, Robyn J. MD, Daniel MD, Richard F. MD, James W. MD, Anurag MD, Bruce L. MD,